Holen Sie sich die Stockscreener-App
13.16
5.39%
-0.75
Handel nachbörslich:
13.49
0.33
+2.51%
Schlusskurs vom Vortag:
$13.91
Offen:
$13.7
24-Stunden-Volumen:
1.49M
Relative Volume:
1.21
Marktkapitalisierung:
$1.28B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-137.25M
KGV:
-6.963
EPS:
-1.89
Netto-Cashflow:
$-121.97M
1W Leistung:
-6.80%
1M Leistung:
+22.08%
6M Leistung:
+157.53%
1J Leistung:
+37.95%
1-Tages-Spanne:
$13.15
$13.78
1-Wochen-Bereich:
$13.15
$14.61
52-Wochen-Spanne:
$3.8951
$14.93
Oric Pharmaceuticals Inc Stock (ORIC) Company Profile
Firmenname
Oric Pharmaceuticals Inc
Sektor
Branche
Telefon
(650) 388-5600
Adresse
240 E. GRAND AVE., SOUTH SAN FRANCISCO, CA
Vergleichen Sie ORIC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ORIC
Oric Pharmaceuticals Inc
|
13.16 | 1.33B | 0 | -137.25M | -121.97M | -1.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Oric Pharmaceuticals Inc Stock (ORIC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-04 | Fortgesetzt | Guggenheim | Buy |
| 2025-07-08 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2024-10-31 | Eingeleitet | Wells Fargo | Overweight |
| 2024-09-06 | Eingeleitet | Stifel | Buy |
| 2024-02-23 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-09-22 | Eingeleitet | Wedbush | Outperform |
| 2023-03-23 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2023-03-21 | Hochstufung | Guggenheim | Neutral → Buy |
| 2023-03-16 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2022-07-18 | Fortgesetzt | Oppenheimer | Perform |
| 2022-04-04 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-03-25 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2022-03-22 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-03-22 | Herabstufung | Guggenheim | Buy → Neutral |
| 2022-03-22 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2021-07-06 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-01-25 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-08-13 | Eingeleitet | Robert W. Baird | Outperform |
| 2020-08-06 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-08-03 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-05-19 | Eingeleitet | Citigroup | Neutral |
| 2020-05-19 | Eingeleitet | Guggenheim | Buy |
| 2020-05-19 | Eingeleitet | JP Morgan | Overweight |
| 2020-05-19 | Eingeleitet | Jefferies | Buy |
Alle ansehen
Oric Pharmaceuticals Inc Aktie (ORIC) Neueste Nachrichten
ORIC Pharmaceuticals Inc Stock Analysis and ForecastMarket Sentiment Surveys & Insights From Wall Street Professionals - earlytimes.in
Will breakout in ORIC Pharmaceuticals Inc. lead to full recoveryRate Hike & Low Drawdown Investment Strategies - newser.com
Oric Pharmaceuticals, Inc. (NASDAQ:ORIC) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Analyzing drawdowns of ORIC Pharmaceuticals Inc. with statistical toolsVolume Spike & Proven Capital Preservation Methods - newser.com
What technical models suggest about ORIC Pharmaceuticals Inc.’s comebackVolume Spike & Reliable Price Action Trade Plans - newser.com
Oric Pharmaceuticals' (ORIC) Sell (D-) Rating Reiterated at Weiss Ratings - MarketBeat
Historical volatility pattern of ORIC Pharmaceuticals Inc. visualized2025 Bull vs Bear & Growth Focused Entry Point Reports - newser.com
Oric Pharmaceuticals (NASDAQ:ORIC) CEO Jacob Chacko Sells 37,461 Shares - MarketBeat
Oric Pharmaceuticals (NASDAQ:ORIC) CFO Sells $159,720.00 in Stock - MarketBeat
How robust is ORIC Pharmaceuticals Inc. (4TZ) stock financial position2025 Major Catalysts & High Accuracy Trade Alerts - newser.com
Oric Pharma CFO sells $159,718 in shares By Investing.com - Investing.com Canada
ORIC Pharmaceuticals Inc. stock trend forecast2025 Market Sentiment & Free Reliable Trade Execution Plans - newser.com
Visual analytics tools that track ORIC Pharmaceuticals Inc. performanceJuly 2025 Rallies & Community Supported Trade Ideas - newser.com
Candlestick signals on ORIC Pharmaceuticals Inc. stock today2025 Technical Overview & Safe Capital Growth Tips - newser.com
Insider Sell: Dominic Piscitelli Sells 11,000 Shares of ORIC Pha - GuruFocus
Oric Pharmaceuticals CEO Chacko Jacob sells $461k in stock By Investing.com - Investing.com Canada
Oric Pharmaceuticals stock hits 52-week high at 14.89 USD By Investing.com - Investing.com Nigeria
Oric Pharmaceuticals (NASDAQ:ORIC) Sets New 12-Month HighStill a Buy? - MarketBeat
Oric Pharmaceuticals (NASDAQ:ORIC) Trading Up 9.8%Here's What Happened - MarketBeat
What analysts say about ORIC Pharmaceuticals Inc stockGrowth Stock Opportunities & High Yield Trading Signals - earlytimes.in
How higher bond yields impact ORIC Pharmaceuticals Inc. (4TZ) stockJuly 2025 Price Swings & Verified Momentum Stock Alerts - newser.com
Top chart patterns to watch in ORIC Pharmaceuticals Inc.Stop Loss & Fast Gaining Stock Strategy Reports - newser.com
Will ORIC Pharmaceuticals Inc. stock attract ESG investorsJuly 2025 Update & Technical Buy Zone Confirmation - newser.com
Identifying reversal signals in ORIC Pharmaceuticals Inc.July 2025 Setups & AI Powered Market Entry Ideas - newser.com
How to use a screener to detect ORIC Pharmaceuticals Inc. breakouts2025 Bull vs Bear & Technical Pattern Based Buy Signals - newser.com
Published on: 2025-10-05 04:16:39 - newser.com
We're Not Very Worried About ORIC Pharmaceuticals' (NASDAQ:ORIC) Cash Burn Rate - Yahoo Finance
Published on: 2025-10-03 04:25:32 - newser.com
Is ORIC Pharmaceuticals Inc. stock poised for growth2025 Short Interest & Stepwise Trade Signal Guides - newser.com
Insider Selling: Oric Pharmaceuticals (NASDAQ:ORIC) CEO Sells 53,001 Shares of Stock - MarketBeat
Voya Investment Management LLC Reduces Position in Oric Pharmaceuticals, Inc. $ORIC - Defense World
ORIC Pharmaceuticals Inc 4TZ Stock Analysis and ForecastMarket Correction Analysis & Expert-Backed Recommendations That Deliver - earlytimes.in
Published on: 2025-09-29 09:52:14 - newser.com
Finanzdaten der Oric Pharmaceuticals Inc-Aktie (ORIC)
Umsatz
Nettogewinn
Free Cashflow
ENV
Oric Pharmaceuticals Inc-Aktie (ORIC) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Piscitelli Dominic | Chief Financial Officer |
Oct 06 '25 |
Sale |
14.52 |
11,000 |
159,719 |
48,317 |
| Chacko Jacob | PRESIDENT AND CEO |
Oct 06 '25 |
Sale |
12.32 |
37,461 |
461,520 |
531,419 |
5.15%
1.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):